Quantitating Endosomal Escape of a Library of Polymers for mRNA Delivery.

Endosomal escape is a key step for intracellular drug delivery of nucleic acids, but reliable and sensitive methods for its quantitation remain an unmet need. In order to rationally optimize the mRNA transfection efficiency of a library of polymeric materials, we designed a deactivated Renilla luciferase-derived molecular probe whose activity can be restored only in the cytosol. This probe can be coencapsulated with mRNA in the same delivery vehicle, thereby accurately measuring its endosomal escape efficiency. We examined a library of poly(amine-co-ester) (PACE) polymers with different end groups using this probe and observed a strong correlation between endosomal escape and transfection efficiency (R2 = 0.9334). In addition, we found that mRNA encapsulation efficiency and endosomal escape, but not uptake, were determinant factors for transfection efficiency. The polymers with high endosomal escape/transfection efficiency in vitro also showed good transfection efficiency in vivo, and mRNA expression was primarily observed in spleens after intravenous delivery. Together, our study suggests that the luciferase probe can be used as an effective tool to quantitate endosomal escape, which is essential for rational optimization of intracellular drug delivery systems.

[1]  A. Kabanov,et al.  SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  P. Kantoff,et al.  Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA , 2018, Nature Biomedical Engineering.

[3]  Angus P R Johnston,et al.  The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery. , 2018, Bioconjugate chemistry.

[4]  Hao Yin,et al.  Delivery technologies for genome editing , 2017, Nature Reviews Drug Discovery.

[5]  J. Zia,et al.  Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. , 2003, The Biochemical journal.

[6]  M. Pittet,et al.  The spleen in local and systemic regulation of immunity. , 2013, Immunity.

[7]  P. Stayton,et al.  Diblock copolymers with tunable pH transitions for gene delivery. , 2012, Biomaterials.

[8]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  W. Hennink,et al.  Endosomal Escape of Polymeric Gene Delivery Complexes Is Not Always Enhanced by Polymers Buffering at Low pH , 2004 .

[10]  W. Saltzman,et al.  Tunability of Biodegradable Poly(amine- co-ester) Polymers for Customized Nucleic Acid Delivery and Other Biomedical Applications. , 2018, Biomacromolecules.

[11]  Liwu Fu,et al.  Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs , 2018, EBioMedicine.

[12]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[13]  P. Cresswell,et al.  A novel probe to assess cytosolic entry of exogenous proteins , 2018, Nature Communications.

[14]  A. Kabanov,et al.  A simple and highly effective catalytic nanozyme scavenger for organophosphorus neurotoxins , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[15]  L. McCullough,et al.  Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery , 2016, Pharmacology Biochemistry and Behavior.

[16]  A. Kabanov,et al.  SOD1 nanozyme with reduced toxicity and MPS accumulation. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Thommey P. Thomas,et al.  Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations. , 2009, Biomacromolecules.

[18]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[19]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[20]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[21]  R. Powers,et al.  Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling , 2017, Translational research : the journal of laboratory and clinical medicine.

[22]  Christopher J. Cheng,et al.  A "top-down" approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery. , 2018, Biomaterials.

[23]  S. Diamond,et al.  Adenovirus or HA‐2 fusogenic peptide‐assisted lipofection increases cytoplasmic levels of plasmid in nondividing endothelium with little enhancement of transgene expression , 2002, The journal of gene medicine.

[24]  Daniel G. Anderson,et al.  Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.

[25]  Kaitlyn Sadtler,et al.  Optimization of a Degradable Polymer-Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells. , 2018, Nano letters.

[26]  Angus P R Johnston,et al.  Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[27]  Paul H. Johnson,et al.  pH-responsive polymeric micelle carriers for siRNA drugs. , 2010, Biomacromolecules.

[28]  Jerilyn A Timlin,et al.  Delivering CRISPR: a review of the challenges and approaches , 2018, Drug delivery.

[29]  Andrew D. Miller,et al.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. , 2004, Biochemistry.

[30]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[31]  Örn Almarsson,et al.  A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[33]  Ronald A. Li,et al.  Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction , 2013, Nature Biotechnology.

[34]  K. Shin,et al.  Determining the Effects of PEI Adsorption on the Permeability of DPPC / BMP Membranes under Osmotic Stress , 2017 .

[35]  S. Futaki,et al.  Octaarginine- and Octalysine-modified Nanoparticles Have Different Modes of Endosomal Escape* , 2008, Journal of Biological Chemistry.

[36]  A. Jones,et al.  Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  C. Benoist,et al.  A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. , 1996, Human gene therapy.